FDA panel unanimously recommends third Covid vaccine as J&J wins key vote in path to emergency use

  • 📰 CNBC
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 72%

United States Headlines News

United States Latest News,United States Headlines

BREAKING: An FDA advisory panel unanimously recommends J&J’s single-shot vaccine for emergency use. megtirrell reports.

, the FDA authorized those companies' vaccinations a day after the committee backed emergency use authorization. If J&J's follows the pattern, a third vaccine could be authorized on Saturday.

Initially, doses would be limited. The U.S. plans to ship 3 million to 4 million doses of J&J's vaccine to states, pharmacies and community health centers next week, pending FDA authorization, Jeff Zients, President Joe Biden's Covid czar, told reporters on Wednesday. The company expects to deliver 20 million doses by the end of March, J&J's vice president of U.S. medical affairs, Dr. Richard Nettles,on Tuesday. J&J has a deal with the U.S.

An EUA means the FDA will allow some people to receive the vaccine as the agency continues to evaluate data. It isn't the same as full approval, which requires more data and can typically take several months longer. J&J, like Pfizer and Moderna, has submitted only two months of safety data, but the agency usually requires six months for full approval. The company is asking the FDA to approve the use of the vaccine in people age 18 and older.to the FDA on Feb. 4.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

megtirrell Now give us $KMPH

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.